Hoffman Michael B's Form 4 filing
Annovis Bio, Inc. (ANVS) · filed Nov 25, 2025
- Accession no.
- 0001104659-25-115801
- Filed
- Nov 25, 2025
- Trade date
- Nov 24, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $159.9K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001104659-25-116084 (Nov 25, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman Michael BCIK 0001290208 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Common Stock | PPurchaseAcquired | +1,489 | $4.13 | +$6,149.57 | 2,482,028 | Direct | |
| Nov 24, 2025 | Common Stock | PPurchaseAcquired | +9,200 | $3.85 | +$35,420 | 2,491,228 | Direct | |
| Nov 24, 2025 | Common Stock | PPurchaseAcquired | +415 | $4.14 | +$1,718.1 | 2,491,643 | Direct | |
| Nov 24, 2025 | Common Stock | PPurchaseAcquired | +28,096 | $4.15 | +$116,598.4 | 2,519,739 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.